Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Royalty Pharma Plc (RPRX) since 2020 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Royalty Pharma Plc. Table 2 shows the detailed insider transactions. This company's CIK number is 1802768.
Total stock buying since 2020: $152,553,065.
Total stock sales since 2020: $682,133,742.
Total stock option exercises since 2020: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 0 | $0 | 470,000 | $13,223,052 | 0 | $0 |
| 2023 | 600,000 | $19,311,026 | 2,644,875 | $86,688,993 | 0 | $0 |
| 2022 | 32,500 | $1,218,360 | 3,649,311 | $151,440,573 | 0 | $0 |
| 2021 | 25,700 | $1,203,479 | 2,085,038 | $90,654,503 | 0 | $0 |
| 2020 | 4,672,150 | $130,820,200 | 7,764,250 | $340,126,621 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2024-01 | 0 | $0 | 470,000 | $13,223,052 | 0 | $0 |
| 2023-12 | 0 | $0 | 251,592 | $7,087,721 | 0 | $0 |
| 2023-08 | 0 | $0 | 75,000 | $2,305,012 | 0 | $0 |
| 2023-07 | 0 | $0 | 75,000 | $2,325,225 | 0 | $0 |
| 2023-06 | 220,000 | $6,796,695 | 192,221 | $6,473,692 | 0 | $0 |
| 2023-05 | 380,000 | $12,514,331 | 1,750,000 | $57,435,000 | 0 | $0 |
| 2023-03 | 0 | $0 | 252,729 | $9,260,443 | 0 | $0 |
| 2023-02 | 0 | $0 | 48,333 | $1,801,900 | 0 | $0 |
| 2022-12 | 0 | $0 | 382,756 | $16,815,616 | 0 | $0 |
| 2022-11 | 0 | $0 | 150,000 | $6,381,821 | 0 | $0 |
| 2022-09 | 0 | $0 | 2,009,972 | $83,098,845 | 0 | $0 |
| 2022-08 | 0 | $0 | 98,348 | $4,289,175 | 0 | $0 |
| 2022-07 | 0 | $0 | 102,480 | $4,435,170 | 0 | $0 |
| 2022-06 | 0 | $0 | 153,333 | $6,428,854 | 0 | $0 |
| 2022-05 | 0 | $0 | 523,333 | $21,013,216 | 0 | $0 |
| 2022-03 | 0 | $0 | 229,089 | $8,977,876 | 0 | $0 |
| 2022-02 | 32,500 | $1,218,360 | 0 | $0 | 0 | $0 |
| 2021-12 | 0 | $0 | 184,448 | $7,400,841 | 0 | $0 |
| 2021-11 | 0 | $0 | 464,389 | $19,698,694 | 0 | $0 |
| 2021-09 | 0 | $0 | 128,425 | $4,693,171 | 0 | $0 |
| 2021-07 | 0 | $0 | 242,898 | $10,144,332 | 0 | $0 |
| 2021-06 | 0 | $0 | 482,700 | $21,739,721 | 0 | $0 |
| 2021-05 | 0 | $0 | 2,000 | $82,159 | 0 | $0 |
| 2021-04 | 0 | $0 | 56,522 | $2,379,808 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-01-04 | Riggs Rory B | Sale | 35,702 | 27.55 | 983,518 |
| 2024-01-03 | Riggs Rory B | Sale | 199,098 | 27.79 | 5,532,336 |
| 2024-01-02 | Riggs Rory B | Sale | 235,200 | 28.52 | 6,707,198 |
| 2023-12-28 | Giuliani Mario Germano | Sale | 209,863 | 28.20 | 5,918,976 |
| 2023-12-27 | Giuliani Mario Germano | Sale | 41,729 | 28.01 | 1,168,745 |
| 2023-08-10 | Coyne Terrance P. (EVP & CFO) | Sale | 37,500 | 30.75 | 1,153,087 |
| 2023-08-09 | Coyne Terrance P. (EVP & CFO) | Sale | 37,500 | 30.72 | 1,151,925 |
| 2023-07-13 | Coyne Terrance P. (EVP & CFO) | Sale | 37,500 | 30.93 | 1,159,950 |
| 2023-07-12 | Coyne Terrance P. (EVP & CFO) | Sale | 37,500 | 31.07 | 1,165,275 |
| 2023-06-28 | Legorreta Pablo G. (CEO, Chairman of the Board) | Buy | 130,000 | 29.51 | 3,836,820 |
| 2023-06-13 | Legorreta Pablo G. (CEO, Chairman of the Board) | Buy | 45,000 | 32.78 | 1,474,920 |
| 2023-06-12 | Legorreta Pablo G. (CEO, Chairman of the Board) | Buy | 45,000 | 33.00 | 1,484,955 |
| 2023-06-06 | Lloyd George W. (EVP, Investments & CLO) | Sale | 79,099 | 33.82 | 2,674,811 |
| 2023-06-05 | Lloyd George W. (EVP, Investments & CLO) | Sale | 19,215 | 33.54 | 644,451 |
| 2023-06-02 | Lloyd George W. (EVP, Investments & CLO) | Sale | 93,907 | 33.59 | 3,154,430 |
| 2023-05-24 | Legorreta Pablo G. (CEO, Chairman of the Board) | Buy | 150,000 | 32.25 | 4,837,500 |
| 2023-05-22 | Riggs Rory B (Director) | Sale | 1,750,000 | 32.82 | 57,435,000 |
| 2023-05-17 | Legorreta Pablo G. (CEO, Chairman of the Board) | Buy | 69,612 | 32.94 | 2,293,088 |
| 2023-05-16 | Legorreta Pablo G. (CEO, Chairman of the Board) | Buy | 160,388 | 33.57 | 5,383,743 |
| 2023-03-30 | Riggs Rory B (Director) | Sale | 130,024 | 36.26 | 4,714,410 |
| 2023-03-29 | Lloyd George W. (EVP, Investments & CLO) | Sale | 12,779 | 37.03 | 473,168 |
| 2023-03-29 | Riggs Rory B (Director) | Sale | 9,926 | 36.95 | 366,765 |
| 2023-03-28 | Lloyd George W. (EVP, Investments & CLO) | Sale | 100,000 | 37.06 | 3,706,100 |
| 2023-02-23 | Lloyd George W. (EVP, Investments & CLO) | Sale | 25,000 | 37.27 | 931,650 |
| 2023-02-22 | Urist Marshall (EVP, Research & Investments) | Sale | 23,333 | 37.30 | 870,250 |
| 2022-12-09 | Riggs Rory B (Director) | Sale | 19,990 | 42.07 | 840,939 |
| 2022-12-02 | Avara Management Ltd | Sale | 197,766 | 43.98 | 8,697,353 |
| 2022-12-01 | Avara Management Ltd | Sale | 165,000 | 44.10 | 7,277,324 |
| 2022-11-17 | Riggs Rory B (Director) | Sale | 120,000 | 42.33 | 5,079,960 |
| 2022-11-08 | Coyne Terrance P. (EVP & CFO) | Sale | 24,500 | 43.47 | 1,065,015 |
| 2022-11-02 | Coyne Terrance P. (EVP & CFO) | Sale | 5,500 | 43.06 | 236,846 |
| 2022-09-28 | Avara Management Ltd | Sale | 32,593 | 41.05 | 1,337,942 |
| 2022-09-28 | Reddoch James F. (EVP & Chief Scientific Officer) | Sale | 100,000 | 41.23 | 4,122,699 |
| 2022-09-22 | Avara Management Ltd | Sale | 211,380 | 41.17 | 8,702,091 |
| 2022-09-21 | Avara Management Ltd | Sale | 125,697 | 41.25 | 5,185,378 |
| 2022-09-20 | Avara Management Ltd | Sale | 398,145 | 41.02 | 16,330,713 |
| 2022-09-20 | Gg 1978 Sicaf Sif S.a. | Sale | 267,815 | 41.02 | 10,985,771 |
| 2022-09-19 | Mgg Strategic Sicaf Sif S.a. | Sale | 232,185 | 41.50 | 9,635,677 |
| 2022-09-19 | Gg 1978 Sicaf Sif S.a. | Sale | 232,185 | 41.50 | 9,635,677 |
| 2022-09-16 | Mgg Strategic Sicaf Sif S.a. | Sale | 154,986 | 41.72 | 6,466,170 |
| 2022-09-16 | Gg 1978 Sicaf Sif S.a. | Sale | 154,986 | 41.72 | 6,466,325 |
| 2022-09-15 | Riggs Rory B (Director) | Sale | 52,025 | 42.21 | 2,195,975 |
| 2022-09-14 | Riggs Rory B (Director) | Sale | 47,975 | 42.41 | 2,034,427 |
| 2022-08-25 | Avara Management Ltd | Sale | 500 | 44.00 | 22,000 |
| 2022-08-25 | Gg 1978 Sicaf Sif S.a. | Sale | 1,994 | 44.00 | 87,736 |
| 2022-08-10 | Lloyd George W. (EVP, Investments & GC) | Sale | 8,995 | 43.92 | 395,105 |
| 2022-08-09 | Lloyd George W. (EVP, Investments & GC) | Sale | 11,859 | 43.92 | 520,799 |
| 2022-08-09 | Riggs Rory B (Director) | Sale | 45,000 | 43.73 | 1,967,805 |
| 2022-08-01 | Coyne Terrance P. (EVP & CFO) | Sale | 30,000 | 43.19 | 1,295,730 |
| 2022-07-28 | Lloyd George W. (EVP, Investments & GC) | Sale | 4,046 | 43.97 | 177,894 |
| 2022-07-27 | Lloyd George W. (EVP, Investments & GC) | Sale | 25,100 | 43.83 | 1,100,158 |
| 2022-07-26 | Urist Marshall (EVP, Research & Investments) | Sale | 19,734 | 43.20 | 852,469 |
| 2022-07-26 | Lloyd George W. (EVP, Investments & GC) | Sale | 19,329 | 43.08 | 832,654 |
| 2022-07-25 | Urist Marshall (EVP, Research & Investments) | Sale | 3,600 | 43.05 | 154,983 |
| 2022-07-25 | Lloyd George W. (EVP, Investments & GC) | Sale | 30,671 | 42.94 | 1,317,012 |
| 2022-06-29 | Riggs Rory B (Director) | Sale | 30,000 | 42.17 | 1,265,250 |
| 2022-06-24 | Urist Marshall (EVP, Research & Investments) | Sale | 23,333 | 43.19 | 1,007,705 |
| 2022-06-08 | Reddoch James F. (EVP & Chief Scientific Officer) | Sale | 100,000 | 41.56 | 4,155,899 |
| 2022-05-27 | Lloyd George W. (EVP, Investments & GC) | Sale | 13,974 | 40.77 | 569,747 |
| 2022-05-27 | Reddoch James F. (EVP & Chief Scientific Officer) | Sale | 75,000 | 41.08 | 3,081,000 |
| 2022-05-26 | Lloyd George W. (EVP, Investments & GC) | Sale | 86,026 | 40.21 | 3,459,363 |
| 2022-05-23 | Lloyd George W. (EVP, Investments & GC) | Sale | 100,000 | 40.27 | 4,026,800 |
| 2022-05-20 | Riggs Rory B (Director) | Sale | 123,696 | 39.28 | 4,858,655 |
| 2022-05-19 | Reddoch James F. (EVP & Chief Scientific Officer) | Sale | 75,000 | 40.44 | 3,033,150 |
| 2022-05-19 | Riggs Rory B (Director) | Sale | 26,304 | 40.09 | 1,054,658 |
| 2022-05-16 | Urist Marshall (EVP, Research & Investments) | Sale | 23,333 | 39.85 | 929,843 |
| 2022-03-29 | Riggs Rory B (Director) | Sale | 60,000 | 38.59 | 2,315,340 |
| 2022-03-21 | Riggs Rory B (Director) | Sale | 39,867 | 39.05 | 1,556,846 |
| 2022-03-18 | Riggs Rory B (Director) | Sale | 129,222 | 39.51 | 5,105,690 |
| 2022-02-24 | Fernandez Henry A (Director) | Buy | 32,500 | 37.49 | 1,218,360 |
| 2021-12-29 | Riggs Rory B (Director) | Sale | 75,000 | 40.01 | 3,000,375 |
| 2021-12-28 | Riggs Rory B (Director) | Sale | 109,448 | 40.21 | 4,400,466 |
| 2021-11-17 | Lloyd George W. (EVP, Investments & GC) | Sale | 84,148 | 42.39 | 3,566,865 |
| 2021-11-17 | Riggs Rory B (Director) | Sale | 201,824 | 42.35 | 8,547,851 |
| 2021-11-16 | Lloyd George W. (EVP, Investments & GC) | Sale | 165,852 | 42.55 | 7,056,173 |
| 2021-11-16 | Riggs Rory B (Director) | Sale | 12,565 | 42.01 | 527,805 |
| 2021-09-29 | Riggs Rory B (Director) | Sale | 88,425 | 36.45 | 3,223,091 |
| 2021-09-28 | Riggs Rory B (Director) | Sale | 40,000 | 36.75 | 1,470,080 |
| 2021-07-26 | Lloyd George W. (EVP, Investments & GC) | Sale | 13,362 | 39.79 | 531,620 |
| 2021-07-26 | Reddoch James F. (EVP, Research & Investments) | Sale | 17,898 | 39.78 | 711,946 |
| 2021-07-14 | Reddoch James F. (EVP, Research & Investments) | Sale | 2 | 42.00 | 84 |
| 2021-07-13 | Lloyd George W. (EVP, Investments & GC) | Sale | 23,049 | 42.01 | 968,242 |
| 2021-07-13 | Reddoch James F. (EVP, Research & Investments) | Sale | 17,832 | 42.01 | 749,086 |
| 2021-07-12 | Lloyd George W. (EVP, Investments & GC) | Sale | 100 | 42.04 | 4,204 |
| 2021-07-12 | Reddoch James F. (EVP, Research & Investments) | Sale | 100 | 42.04 | 4,204 |
| 2021-07-08 | Lloyd George W. (EVP, Investments & GC) | Sale | 49,059 | 42.05 | 2,062,832 |
| 2021-07-08 | Reddoch James F. (EVP, Research & Investments) | Sale | 40,655 | 42.05 | 1,709,380 |
| 2021-07-07 | Lloyd George W. (EVP, Investments & GC) | Sale | 2,900 | 42.01 | 121,834 |
| 2021-07-07 | Reddoch James F. (EVP, Research & Investments) | Sale | 2,192 | 42.01 | 92,085 |
| 2021-07-06 | Lloyd George W. (EVP, Investments & GC) | Sale | 36,530 | 42.41 | 1,549,273 |
| 2021-07-06 | Reddoch James F. (EVP, Research & Investments) | Sale | 30,270 | 42.40 | 1,283,569 |
| 2021-06-10 | Lloyd George W. (EVP, Investments & GC) | Sale | 70,000 | 46.48 | 3,253,250 |
| 2021-06-08 | Lloyd George W. (EVP, Investments & GC) | Sale | 70,000 | 46.48 | 3,253,460 |
| 2021-06-07 | Urist Marshall (EVP & Co-Head of R&I) | Sale | 16,568 | 47.02 | 779,060 |
| 2021-06-07 | Lloyd George W. (EVP, Investments & GC) | Sale | 122,500 | 46.34 | 5,676,160 |
| 2021-06-04 | Urist Marshall (EVP & Co-Head of R&I) | Sale | 16,566 | 45.13 | 747,656 |
| 2021-06-04 | Lloyd George W. (EVP, Investments & GC) | Sale | 60,000 | 44.78 | 2,686,920 |
| 2021-06-02 | Urist Marshall (EVP & Co-Head Research & Inv.) | Sale | 14,566 | 41.52 | 604,853 |
| 2021-06-02 | Lloyd George W. (EVP, Investments & GC) | Sale | 62,500 | 42.11 | 2,631,812 |
| 2021-06-02 | Reddoch James F. (EVP, Research & Investments) | Sale | 50,000 | 42.13 | 2,106,550 |
| 2021-05-21 | Urist Marshall (EVP & Co-Head Research & Inv.) | Sale | 100 | 41.00 | 4,100 |
| 2021-05-20 | Urist Marshall (EVP & Co-Head Research & Inv.) | Sale | 1,900 | 41.08 | 78,059 |
| 2021-04-14 | Reddoch James F. (EVP, Research & Investments) | Sale | 55,714 | 42.10 | 2,345,615 |
| 2021-04-12 | Lloyd George W. (EVP, Investments & GC) | Sale | 449 | 42.32 | 19,001 |
| 2021-04-12 | Reddoch James F. (EVP, Research & Investments) | Sale | 359 | 42.32 | 15,192 |
| 2021-03-22 | Lloyd George W. (EVP, Investments & GC) | Sale | 54,729 | 46.56 | 2,548,455 |
| 2021-03-22 | Reddoch James F. (EVP, Research & Investments) | Sale | 43,927 | 46.32 | 2,034,522 |
| 2021-03-03 | Coyne Terrance P. (EVP & CFO) | Sale | 100,000 | 45.37 | 4,537,000 |
| 2021-03-02 | Lloyd George W. (EVP, Investments & GC) | Sale | 125,000 | 47.37 | 5,921,000 |
| 2021-03-02 | Coyne Terrance P. (EVP & CFO) | Sale | 100,000 | 47.38 | 4,738,300 |
| 2021-03-02 | Reddoch James F. (EVP, Research & Investments) | Sale | 100,000 | 47.37 | 4,736,500 |
| 2021-02-25 | Fernandez Henry A | Buy | 25,700 | 46.83 | 1,203,479 |
| 2020-12-18 | Gross Phillip | Sale | 101,050 | 44.02 | 4,448,221 |
| 2020-12-17 | Gross Phillip | Sale | 7,200,000 | 43.92 | 316,224,000 |
| 2020-10-20 | Riggs Rory B | Sale | 463,200 | 42.00 | 19,454,400 |
| 2020-06-18 | Lloyd George W. (EVP, Investments & GC) | Buy | 14,200 | 28.00 | 397,600 |
| 2020-06-18 | Nogra Group Sicaf Sif Gg Strategic | Buy | 50,000 | 28.00 | 1,400,000 |
| 2020-06-18 | Coyne Terrance P. (EVP & CFO) | Buy | 2,950 | 28.00 | 82,600 |
| 2020-06-18 | Hite Christopher (EVP & Vice Chairman) | Buy | 70,000 | 28.00 | 1,960,000 |
| 2020-06-18 | Legorreta Pablo G. (CEO, Chairman of the Board) | Buy | 20,000 | 28.00 | 560,000 |
| 2020-06-18 | Gross Phillip | Buy | 3,000,000 | 28.00 | 84,000,000 |
| 2020-06-18 | Ford William E | Buy | 1,500,000 | 28.00 | 42,000,000 |
| 2020-06-18 | Riggs Rory B | Buy | 15,000 | 28.00 | 420,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of RPRX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Royalty Pharma Plc (symbol RPRX, CIK number 1802768) see the Securities and Exchange Commission (SEC) website.